The presence of MEN1 in ZES patients has important effects on the pathology of the gastrinoma and its behavior, the prognosis of the patient, and all aspects of the management of the patient, including the need for genetic counseling. Here, MEN1 is linked to gastrin-producing neuroendocrine tumor.